Viridian Capital Advisors



Viridian Capital Advisors Recent News

Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
Webinar: A Look At The Cannabis Industry's $700M Potential Tax Break Amid A 70% Drop In Capital Raises
35 Cannabis Innovators To Watch In 2024: Leaders Shaping The Green Revolution
Cannabis Stocks With Hidden Potential: A Closer Look At Attractively-Valued Tier-2 Firms
Trulieve Vs The IRS Over Millions Of Dollars In Tax Refund, Relocates One Of Its Florida Stores
Viridian Capital Advisors Led A Panel On If M&As Are On The Rise In The Cannabis Industry
Sponsored
Pennsylvania Stands Up To Federal Law On Medical Cannabis Taxes
EXCLUSIVE: How Regulatory Reforms Could Reshape M&A Pulse In Cannabis Industry
Cannabis Capital: Which State Is Getting The Most Investment Money? It's Not California Or Colorado
Cannabis Valuation Jumps Post-Rescheduling Recommendation, Viridian Report Reveals
Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
Director Of MA Marijuana Regulator Resigns, MD Plans To Evaluate Pot's Health Effects And Recent Industry Moves
Cannabis Investments: Which States Are Getting The Most Capital? Here's The Top 10
Cannabis Investing Got You Down? Confused? You're Not Alone, Help Is On The Way
Exclusive Tool For Cannabis Investors And Entrepreneurs Goes Online After 8-Year Email Run
Scott Greiper Of Viridian Capital Advisors Leads Panel At Benzinga Cannabis Capital Conference
Sponsored
This Is The Best Investment Research Firm In Cannabis In 2022, According To Industry Experts
'The World's Largest Database Of Cannabis Deals Gives Us Incredible Market Intelligence And An Edge,' Says Viridian's Scott Greiper
Analyst: AYR Wellness Weakness on Guidance Overlooks Longer-Term Opportunity
Viridian Capital Advisors' Pres Scott Greiper To Be Featured At Benzinga's Cannabis Capital Conference
It's a Done Deal: 365 Cannabis Sold to Akerna
Analyst Explains Why Jushi Is One Of The Best Cannabis Stocks Among Leading MSOs